Pharmaceutical preparations company · L3 · FY ends Dec · Revenue $1.24B · -0.40% margin · -$5M FCF
The business is unprofitable at the operating level (-0.40% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Negative free cash flow of -$5M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$1.24B
Net Income (TTM)
-$6M
▼ -282.2% YoY
Op. Margin
-0.40%
ROIC
-134.24%
Cash Flow & Balance Sheet
FCF (TTM)
-$5M
▼ -641.7% YoY
Op. Cash Flow (TTM)
-$5M
▼ -639.5% YoY
Net Debt
-$1M
Net Cash Position
Cash & Equiv.
$1M
Continue Research